These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 38287343)
41. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India. Bagchi S; Singh G; Yadav R; Kalaivani M; Mahajan S; Bhowmik D; Dinda A; Agarwal SK Ren Fail; 2016; 38(3):431-6. PubMed ID: 26837482 [TBL] [Abstract][Full Text] [Related]
43. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function. Moriyama T; Amemiya N; Ochi A; Tsuruta Y; Shimizu A; Itabashi M; Takei T; Uchida K; Nitta K Am J Nephrol; 2011; 34(3):233-40. PubMed ID: 21778707 [TBL] [Abstract][Full Text] [Related]
44. Corticosteroids Improve Renal Survival: A Retrospective Analysis From Chinese Patients With Early-Stage IgA Nephropathy. Qin A; Pei G; Tang Y; Tan L; Wei X; Zhong Z; Zhou L; Chen C; Qin W Front Med (Lausanne); 2020; 7():585859. PubMed ID: 33195345 [No Abstract] [Full Text] [Related]
45. Comparison of administration of single- and triple-course steroid pulse therapy combined with tonsillectomy for immunoglobulin A nephropathy. Watanabe-Kusunoki K; Nakazawa D; Yamamoto J; Matsuoka N; Kaneshima N; Nakagaki T; Yamamoto R; Maoka T; Iwasaki S; Tsuji T; Fukasawa Y; Nishimoto N; Nishio S; Atsumi T Medicine (Baltimore); 2021 Dec; 100(50):e27778. PubMed ID: 34918629 [TBL] [Abstract][Full Text] [Related]
46. Immunosuppressive therapy for IgA nephropathy in children. Alladin A; Hahn D; Hodson EM; Ravani P; Pfister K; Quinn RR; Samuel SM Cochrane Database Syst Rev; 2024 Jun; 6(6):CD015060. PubMed ID: 38864363 [TBL] [Abstract][Full Text] [Related]
47. Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial. Hou FF; Xie D; Wang J; Xu X; Yang X; Ai J; Nie S; Liang M; Wang G; Jia N; JAMA Netw Open; 2023 Feb; 6(2):e2254054. PubMed ID: 36745456 [TBL] [Abstract][Full Text] [Related]
48. Risk factors for pregnancy outcomes in patients with IgA nephropathy: a matched cohort study. Liu Y; Ma X; Lv J; Shi S; Liu L; Chen Y; Zhang H Am J Kidney Dis; 2014 Nov; 64(5):730-6. PubMed ID: 25134778 [TBL] [Abstract][Full Text] [Related]
49. [Considerations on the treatment of IgA nephropathy on the basis of the results of the latest studies (STOP-IgAN, TESTING, NEFIGAN)]. Nagy J; Sági B; Máté J; Vas T; Kovács T Orv Hetil; 2017 Dec; 158(49):1946-1952. PubMed ID: 29199436 [TBL] [Abstract][Full Text] [Related]
50. Clinical course of Immunoglobulin A nephropathy with crescents in a multi-ethnic Southeast Asian cohort. Lim CC; Baikunje S; Choo JCJ; Tan PH; Foo M; Woo KT Nephrology (Carlton); 2020 Sep; 25(9):708-713. PubMed ID: 32400945 [TBL] [Abstract][Full Text] [Related]
51. Prognosis of IgA nephropathy patient with proteinuria remission by supportive therapy: cohort from screening failed Chinese patients in TESTING study. Guo Y; Shi S; Zhao J; Wang C; Liu Z; Fu S; Chen N; Li G; Wang L; Ni Z; Zhang H; Lai L; Lv J; Zhang H Ren Fail; 2024 Dec; 46(2):2398826. PubMed ID: 39248402 [TBL] [Abstract][Full Text] [Related]
52. The epidemiology and evolution of IgA nephropathy over two decades: A single centre experience. Storrar J; Chinnadurai R; Sinha S; Kalra PA PLoS One; 2022; 17(9):e0268421. PubMed ID: 36048745 [TBL] [Abstract][Full Text] [Related]
53. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. Pozzi C; Andrulli S; Del Vecchio L; Melis P; Fogazzi GB; Altieri P; Ponticelli C; Locatelli F J Am Soc Nephrol; 2004 Jan; 15(1):157-63. PubMed ID: 14694168 [TBL] [Abstract][Full Text] [Related]
54. The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy. Tsushima H; Samejima KI; Eriguchi M; Uemura T; Tasaki H; Fukata F; Nishimoto M; Kosugi T; Tanabe K; Okamoto K; Matsui M; Tsuruya K Clin Exp Nephrol; 2022 Aug; 26(8):797-807. PubMed ID: 35426595 [TBL] [Abstract][Full Text] [Related]
55. Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study. Tang C; Chen P; Si FL; Lv JC; Shi SF; Zhou XJ; Liu LJ; Zhang H Am J Kidney Dis; 2024 Aug; 84(2):170-178.e1. PubMed ID: 38364955 [TBL] [Abstract][Full Text] [Related]
57. Steroid therapy in children with IgA nephropathy. Cambier A; Boyer O; Deschenes G; Gleeson J; Couderc A; Hogan J; Robert T Pediatr Nephrol; 2020 Mar; 35(3):359-366. PubMed ID: 30778826 [TBL] [Abstract][Full Text] [Related]
58. Comparison between hydroxychloroquine and systemic corticosteroids in IgA nephropathy: a two-year follow-up study. Si FL; Tang C; Lv JC; Shi SF; Zhou XJ; Liu LJ; Zhang H BMC Nephrol; 2023 Jun; 24(1):175. PubMed ID: 37322444 [TBL] [Abstract][Full Text] [Related]
59. Association Between Tonsillectomy and Outcomes in Patients With Immunoglobulin A Nephropathy. Hirano K; Matsuzaki K; Yasuda T; Nishikawa M; Yasuda Y; Koike K; Maruyama S; Yokoo T; Matsuo S; Kawamura T; Suzuki Y JAMA Netw Open; 2019 May; 2(5):e194772. PubMed ID: 31150076 [TBL] [Abstract][Full Text] [Related]
60. Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients. Pesce F; Diciolla M; Binetti G; Naso D; Ostuni VC; Di Noia T; Vågane AM; Bjørneklett R; Suzuki H; Tomino Y; Di Sciascio E; Schena FP Nephrol Dial Transplant; 2016 Jan; 31(1):80-6. PubMed ID: 26047632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]